For OTC And Supplement Success Stories, Firms Need Multiple Writers
This article was originally published in The Tan Sheet
Gaining market share in the increasingly competitive and regulated OTC and supplement sectors requires a collaborative approach with R&D, legal and marketing teams working together from the start, says Novartis Consumer executive Rosanne Rotondo.
You may also be interested in...
Rectal products containing sodium phosphate/sodium biphosphate would be required to bear sodium content and warning statements under a proposed rule published by FDA in the March 24 Federal Register. The proposal would apply the same requirements to rectal sodium phosphate drugs that now apply to other OTCs containing sodium. The action responds to concerns that individuals with certain medical conditions are at risk of an electrolyte imbalance when using such products. Comments are requested by June 22...
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.